FindTrial
Sign In

BB trial; Effect of botox in Piriformis syndrome

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504427-61-01
Enrollment
36
Registered
2023-11-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

piriformis hypertonia

Brief summary

Subjects that are withdrawn from treatment will be seen in the outpatient clinic 12 weeks after de test block.

Interventions

DRUGphysiological NaCl 0.9 %
DRUGBOTULINUM TOXIN TYPE A

Sponsors

Stichting Alrijne Zorggroep
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Subjects that are withdrawn from treatment will be seen in the outpatient clinic 12 weeks after de test block.—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026